Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Compound 7p shows strong potential as an anticancer agent.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Some breast cancer chemotherapy can cause permanent hair loss.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib is safe and may effectively treat alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.